Aptargroup Inc (ATR)
Valor JustoFundamental
66
Preço
$121.16
Capitalização de Mercado
$7.91B
Parte 1 · Quanto vale a empresa
Visão Geral
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18 de setembro de 2026 with claude-haiku-4-5 — shared with all users
It supplies the elastomeric stoppers, seals and injection delivery systems that compete head-on with Aptar Pharma's injectables business for the same drug makers.
Through Silgan Dispensing Systems it makes the same pumps, trigger sprayers and dispensing closures Aptar sells to beauty, home care and food and beverage brands.
This French maker of nasal sprays, preservative-free eyedroppers and inhalers bids for the same drug-delivery device contracts with pharmaceutical companies as Aptar Pharma.
The German group sells inhalers, pen injectors and primary pharmaceutical packaging, and also cosmetics packaging, to the same pharma and beauty customers Aptar serves in Europe and the United States.
After absorbing Berry Global in April 2025 it is a large supplier of closures, dispensing components and healthcare packaging to the consumer and pharmaceutical brands Aptar depends on.
The privately held German closure specialist competes with Aptar's Food + Beverage segment on dispensing and non-dispensing plastic caps for drinks, edible oils and household liquids.
Balanço & Liquidez
Receita
$3.93B
Últimos 12 meses (até 30/06/2026)
Resultado Líquido
$363M
Últimos 12 meses (até 30/06/2026)
Fluxo de Caixa Livre
$300M
Capital Próprio Total
$2.67B
Passivo Total
$2.57B
Rácio de Liquidez
1.61
Cobertura de Juros
7.52
Dívida/EBITDA
1.79
Resultados Por Ação
Receita & Resultado Líquido
Fluxo de Caixa Livre
Decomposição dos Resultados
Demonstração histórica
Margens ao longo do tempo
A dívida ao longo do tempo
Quanto pesa a dívida
Grelha do crescimento
Crescimento — Receitas
Estimativa de Valor Justo
Valor Justo
$154.38
Preço Atual
$121.16
Margem de Segurança
+21.5%
Intervalo de Valor Justo
$116.80 - $191.96
Dispersão entre os métodos de avaliação utilizados, não um intervalo de confiança calibrado estatisticamente.
Métodos de Estimativa
Métricas de Avaliação
Rácio P/E
21.91
ROE
14.7%
Rácio P/B
2.93
P/FCF
24.82
Margem Bruta
-
ROIC
9.4%
Radar de Rentabilidade
Criação de Valor (Vantagem Competitiva)
ROIC
9.4%
WACC
7.2%
ROIC − WACC
+2.2 pp
O ROIC supera o custo do capital — a empresa está a criar valor para os acionistas.
Critérios de Análise Fundamental
Aprovado (21)
- EPS shows upward trend
- EPS CAGR 6.02%
- Price CAGR 5.45%
- ROIC 9.4%
- P/FCF 24.82
- P/B Ratio 2.93
- Debt/Equity ratio
- Operating Margin 12.1%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 13.6%
- Revenue Growth 5Y 5.2%
- Analyst Consensus 83% Buy
- Earnings Surprise avg 4.0%
- PEG Ratio 1.66
- Earnings Quality (OCF/NI) 1.61
- Share Dilution -1.5%
- Piotroski F-Score 5/9
Reprovado (5)
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Net Margin Trend 9.2% vs 10.8%
Indisponível (2)
- Gross Margin NaN%
- Dividend Payout NaN%
Piotroski F-Score
Sinais mistos: algumas áreas requerem atenção
Qualidade dos Resultados
Alta qualidade: resultados respaldados por caixa
Diluição de Ações
A recomprar ações. Favorável ao acionista
Participações institucionais
Não há declarações institucionais para esta empresa.
Governação
Equipa Executiva
| Nome | Cargo | Idade |
|---|---|---|
| Mr. Gael Touya | CEO, President & Director | 55 |
| Ms. Vanessa Kanu | Executive VP & CFO | 47 |
| Mr. Stephan B. Tanda | Director & Advisor | 60 |
| Mr. Marc Prieur | President of Aptar Beauty | 59 |
| Ms. Xiangwei Gong | Executive VP of Strategic Group Development & President of Aptar Asia | 55 |
| Mr. Hedi Tlili | President of Aptar Closures | 50 |
| Mr. Aditya J. Gandhi | VP, Principal Accounting Officer & Chief Accounting Officer | 45 |
| Ms. Mary Skafidas | Senior Vice President of Investor Relations & Communications | - |
| Ms. Irene Hudson | Executive VP, Chief Legal Officer & Corporate Secretary | 48 |
| Ms. Shiela Pallerne Vinczeller | Chief Human Resources Officer | 61 |
Risco de Auditoria
1
Risco do Conselho
1
Risco de Remuneração
2
Risco dos Direitos dos Acionistas
5
Parte 2 · O preço e o momento de entrar
Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.
Documentos
- Ver documento
Relatório anual (10-K)
Uma visão anual do negócio, dos resultados financeiros e dos riscos da empresa.
Arquivado em 2026-02-06
- Ver documento
Relatório trimestral (10-Q)
Uma atualização sobre o desempenho financeiro dos últimos três meses.
Arquivado em 2026-07-31
- Ver documento
Relatório de fato relevante (8-K)
Um aviso sobre um fato relevante, como uma mudança na liderança ou um grande anúncio.
Arquivado em 2026-09-21
via SEC EDGAR
Histórico de Resultados
via SEC EDGAR
Latest News
Recent headlines for ATR, sourced from Markets Gazette.
- 28d agoPOSITIVEATR (JV Leonardo-Airbus), maxi ordine da 1 miliardo di dollari dall'indiana FLY91
Indian regional airline FLY91 has placed a landmark order for 40 ATR 72-600 aircraft, valued at approximately $1 billion. This significant deal represents the largest order for ATR globally from a single airline. The ATR 72-600 is a turboprop regional airliner, and this order underscores FLY91's commitment to expanding its regional network. For investors in Leonardo (a partner in the ATR joint venture), this order signals strong demand for regional aircraft and a positive outlook for the turboprop market, potentially boosting future revenues and profitability.
- 2/28/2026POSITIVERiver Road Loads Up on ATR With 917,000 Shares in New Position
River Road, a prominent investment manager, has announced the establishment of a new significant position in AptarGroup Inc., acquiring 917,000 shares. AptarGroup is a global provider of proprietary dispensing and sealing solutions for the healthcare, beauty, and consumer markets. This strategic move by River Road signals strong confidence in AptarGroup's future prospects, suggesting the company may be undervalued or poised for significant growth. Investors might interpret this as a bullish signal, indicating potential increased interest and demand for ATR shares, given its robust global market positioning.
via Markets Gazette